NVOS
Income statement / Annual
Last year (2024), Novo Integrated Sciences, Inc.'s total revenue was $13.29 M,
an increase of 5.75% from the previous year.
In 2024, Novo Integrated Sciences, Inc.'s net income was -$16.13 M.
See Novo Integrated Sciences, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
08/31/2024 |
08/31/2023 |
08/31/2022 |
08/31/2021 |
08/31/2020 |
08/31/2019 |
08/31/2018 |
08/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$13.29 M |
$12.57 M |
$11.74 M |
$9.31 M |
$7.86 M |
$9.42 M |
$8.89 M |
$7.96 M |
$7.18 M |
$7.47 M |
| Cost of Revenue |
$7.55 M
|
$7.62 M
|
$6.94 M
|
$5.48 M
|
$4.80 M
|
$5.90 M
|
$5.47 M
|
$4.99 M
|
$4.67 M
|
$4.76 M
|
| Gross Profit |
$5.74 M
|
$4.95 M
|
$4.80 M
|
$3.82 M
|
$3.06 M
|
$3.52 M
|
$3.42 M
|
$2.98 M
|
$2.51 M
|
$2.71 M
|
| Gross Profit Ratio |
0.43
|
0.39
|
0.41
|
0.41
|
0.39
|
0.37
|
0.38
|
0.37
|
0.35
|
0.36
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$14.04 M
|
$13.49 M
|
$14.36 M
|
$8.09 M
|
$7.29 M
|
$4.02 M
|
$4.88 M
|
$3.03 M
|
$2.36 M
|
$2.93 M
|
| Selling & Marketing Expenses |
$17,137.00
|
$15,149.00
|
$20,702.00
|
$7,525.00
|
$4,921.00
|
$39,931.00
|
$109,295.00
|
$59,026.00
|
$25,610.00
|
$63,757.00
|
| Selling, General & Administrative Expenses |
$14.06 M
|
$13.51 M
|
$14.39 M
|
$8.10 M
|
$7.29 M
|
$4.06 M
|
$4.99 M
|
$3.09 M
|
$164,887.00
|
$2.99 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$21,900.00
|
-$194,055.00
|
$72,080.00
|
$0.00
|
$0.00
|
$0.00
|
$34,000.00
|
| Operating Expenses |
$14.06 M
|
$13.51 M
|
$14.39 M
|
$8.10 M
|
$7.29 M
|
$4.06 M
|
$4.99 M
|
$3.09 M
|
$164,887.00
|
$401,573.00
|
| Cost And Expenses |
$21.61 M
|
$21.13 M
|
$21.32 M
|
$13.58 M
|
$12.09 M
|
$9.96 M
|
$10.46 M
|
$8.08 M
|
$164,887.00
|
$401,573.00
|
| Interest Income |
$202,525.00
|
$9,027.00
|
$169,088.00
|
$45,687.00
|
$33,627.00
|
$154,793.00
|
$16,702.00
|
$34,139.00
|
$0.00
|
$0.00
|
| Interest Expense |
-$652,398.00
|
$5.12 M
|
$7.57 M
|
$165,003.00
|
$156,662.00
|
$222,155.00
|
$564,467.00
|
$554,657.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$6.70 M
|
$2.30 M
|
$3.02 M
|
$2.37 M
|
$1.99 M
|
$311,865.00
|
$73,447.00
|
$101,664.00
|
$72,586.00
|
$1,011.00
|
| EBITDA |
-$10.08 M |
-$5.85 M |
-$22.48 M |
-$2.58 M |
-$2.78 M |
$130,441.00 |
-$1.48 M |
-$16,693.00 |
-$164,887.00 |
-$277,771.00 |
| EBITDA Ratio |
-0.76
|
-0.47
|
-1.92
|
-0.28
|
-0.35
|
0.01
|
-0.17
|
-0
|
-0.02
|
-0.04
|
| Operating Income Ratio |
-0.76
|
-0.68
|
-2.13
|
-0.47
|
-0.54
|
-0.08
|
-0.18
|
-0.01
|
-0.02
|
-0.05
|
| Total Other Income/Expenses Net |
-$6.05 M
|
-$4.72 M
|
-$8.04 M
|
-$97,416.00
|
-$661,611.00
|
$382,018.00
|
-$547,765.00
|
-$520,518.00
|
$0.00
|
-$2.37 M
|
| Income Before Tax |
-$16.13 M
|
-$13.27 M
|
-$33.07 M
|
-$4.47 M
|
-$4.92 M
|
-$403,579.00
|
-$2.12 M
|
-$633,562.00
|
-$164,887.00
|
-$2.77 M
|
| Income Before Tax Ratio |
-1.21
|
-1.06
|
-2.82
|
-0.48
|
-0.63
|
-0.04
|
-0.24
|
-0.08
|
-0.02
|
-0.37
|
| Income Tax Expense |
$0.00
|
$0.00
|
-$22,302.00
|
$178,115.00
|
-$46,448.00
|
$282,640.00
|
$7,521.00
|
$111,702.00
|
-$72,583.00
|
$2.40 M
|
| Net Income |
-$16.13 M
|
-$13.21 M
|
-$32.85 M
|
-$4.46 M
|
-$4.92 M
|
-$391,984.00
|
-$2.11 M
|
-$738,384.00
|
-$164,887.00
|
-$2.77 M
|
| Net Income Ratio |
-1.21
|
-1.05
|
-2.8
|
-0.48
|
-0.63
|
-0.04
|
-0.24
|
-0.09
|
-0.02
|
-0.37
|
| EPS |
-0.89 |
-1.3 |
-11.28 |
-1.8 |
-2.13 |
-0.18 |
-1.02 |
-0.42 |
-0.74 |
-13.29 |
| EPS Diluted |
-0.89 |
-1.3 |
-11.28 |
-1.8 |
-2.13 |
-0.18 |
-1.02 |
-0.42 |
-0.74 |
-13.29 |
| Weighted Average Shares Out |
$18.03 M
|
$10.17 M
|
$2.91 M
|
$2.48 M
|
$2.30 M
|
$2.17 M
|
$2.08 M
|
$1.78 M
|
$223,626.00
|
$208,514.00
|
| Weighted Average Shares Out Diluted |
$18.03 M
|
$10.17 M
|
$2.91 M
|
$2.48 M
|
$2.30 M
|
$2.17 M
|
$2.08 M
|
$1.78 M
|
$223,626.00
|
$208,514.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
